Strategic Funding VPS has secured multiple funding sources including a recent $2M government grant and earlier grants, signaling strong investor and grant support that can be leveraged to expand sales efforts and validate demand for procurement partners and hospital systems.

Clinical Validation The VP.S ENCORE device has FDA Breakthrough Designation and extensive preclinical testing across multiple heart models, providing a compelling credibility pillar for hospital procurement teams evaluating advanced organ preservation tech.

Key Partnerships Formal collaboration with Texas Organ Sharing Alliance and ongoing research relationships indicate accessible channels to reach transplant centers and obtain donated hearts for trials, offering a pathway to pilots and case studies.

Leadership Momentum Recent appointment of an Interim Chairman and ongoing board-level activity suggest active governance and strategic direction, which can help accelerate decision cycles in hospital networks and supplier procurement negotiations.

Publicity & Recognition Industry award win and media coverage around innovative design position VPS as a differentiated player in a niche but growing market, opening doors with executives seeking cutting-edge, cost-effective preservation solutions.